Skip to Main Content

Chemically-defined complete culture media

OptiVERO®

Product Number 555OCM0039
Form Liquid Complete Media
Origin Animal-Origin Free
Status GMP

A chemically defined, blood-free complete medium formulated for VERO cell expansion and virus production in 2D flask and 3D microcarrier formats.

Replacing serum-supplemented or hydrolysate-based media with OptiVERO provides a consistent, defined formulation and lowers risk.

1 L Kit
$198.50

Composition

Form
Liquid
Kit
980 mL base + 20 mL 50x supplement
Format
Bottles
Storage
Base medium: 2 to 8 °C; Protein supplement: -20 °C

Compliance

Status
Chemically-Defined, AOF
Manufacturing
cGMP, ISO 9001:2015
Facility
Junction City, KS
Documentation
Lot-specific CoA
View complete specifications

Product overview

A chemically defined, blood-free complete medium for VERO cell virus production.

VERO cell programs run on two materials. EMEM or DMEM with 10% fetal bovine serum gives commercially acceptable doubling times, but carries donor-to-donor variability, TSE/BSE risk, and adventitious agent qualification burden, and the volumes a media-intensive vaccine process needs can be impractical to source. Plant-hydrolysate serum-free media such as VP-SFM remove the serum, then reintroduce lot-to-lot variability through high levels of undefined hydrolysates. Guidance from FDA, EMA, and PMDA has progressively encouraged eliminating animal-derived components from vaccine manufacturing.

OptiVERO® is a chemically defined, animal-origin-free complete medium for VERO cells, manufactured at InVitria’s ISO 9001:2015-certified, cGMP-compliant facility in Junction City, Kansas. It ships as a two-component kit: 980 mL base medium plus a 20 mL frozen 50x protein supplement that includes recombinant human serum albumin and recombinant human transferrin. In 3D microcarrier culture, VERO cells reached 1.7 × 10⁶ cells/mL at day 5, against 8.8 × 10⁵ in EMEM-10% FBS and 1.1 × 10⁶ in VP-SFM. In a Pall iCELLis® nano fixed-bed bioreactor, doubling time averaged 27.88 ± 7.56 hours against 34.01 ± 2.24 hours in EMEM-10% FBS, which the white paper reads as equivalent growth kinetics. Users add L-glutamine to 4 mM.

From the published data

See the Data at a Glance

EbolaΔVP30 titer in OptiVERO, EMEM-2% FBS and VP-SFM

Fig. 1 · EbolaΔVP30 titer

4× the Ebola titer of VP-SFM

In EbolaΔVP30 production at the University of Wisconsin–Madison, peak titer at day 6 reached 1.74 × 107 PFU/mL in OptiVERO® versus 1.35 × 107 in EMEM–2% FBS. VP-SFM gave a significant one-log reduction (4.29 × 106), repeated across three experiments.

Alfano et al., Biotechnology & Bioengineering →
Average cumulative population doublings in the iCELLis nano bioreactor

Fig. 2 · iCELLis® bioreactor

Equivalent growth kinetics at fixed-bed scale

In a Pall iCELLis® nano fixed-bed bioreactor, OptiVERO® matched EMEM–10% FBS on cumulative population doublings, with a mean doubling time of 27.88 ± 7.56 h versus 34.01 ± 2.24 h.

Read the white paper →
Dengue virus production in VERO cells in OptiVERO, 10% FBS and VP-SFM

Fig. 3 · Dengue titer

Dengue titer matching serum and VP-SFM

Peak Dengue titer reached 5.3 × 108 PFU/mL in OptiVERO®, against 3.75 × 108 in EMEM–10% FBS and 4.6 × 108 in VP-SFM — equivalent yields without serum or hydrolysates.

Read the application note →

Featured Resources

The published data behind the claims

Technical specifications

Attribute Value
Physical & Chemical
Form Liquid
Appearance Base medium: clear pinkish-red liquid; Protein supplement: colorless to yellow liquid, clear to cloudy
Sterility Supplement Only: Sterile (filtered)
Storage conditions Base medium: 2 to 8 °C; Protein supplement: -20 °C
Shelf life Protein supplement: 2 years from DOM (frozen); Base medium: 2 years from DOM (2 to 8 °C)
Packaging 1 L kit: 980 mL base medium + 20 mL 50x frozen protein supplement
Composition
Product name OptiVERO® Complete Media Kit
Brand InVitria®
SKU / Product Number 555OCM0039
Class Chemically defined, animal-origin-free VERO cell culture medium
Expression System Recombinant, Animal-Origin Free
Cell type VERO
Regulatory
Production standard ISO 9001:2015, cGMP-compliant facility
Country of origin USA (Junction City, KS)
Documentation Certificate of Analysis (request form) · Data Sheet · Guidelines for Use · Certificate of Origin and Animal-Free / TSE-BSE Statement · ISO 9001:2015 certificate · cGMP Statement
Peer-reviewed validation Alfano et al. 2020 Biotechnology and Bioengineering; Vaccines 2023; Preparative Biochemistry & Biotechnology 2024

Key Benefits

Chemically Defined, Blood-Free
OptiVERO®: no serum, plant hydrolysates, or undefined components, with recombinant human proteins only.
Higher Microcarrier Cell Density
1.7 × 10⁶ cells/mL at day 5, versus 8.8 × 10⁵ in EMEM with 10% FBS.
Scales to Fixed-Bed Bioreactors
Expanded VERO cells in iCELLis® bioreactors from 0.53 m² to 2.6 m² of growth surface.
Strong Dengue Virus Yields
In 2D flasks, Dengue titer was 8x VP-SFM and close to EMEM with 10% FBS.
Two-Component 1 L Kit
980 mL base medium plus 20 mL 50x frozen protein supplement; add L-glutamine to 4 mM.

How to order OptiVERO®

Catalog purchase
The 1 L kit is $198.50 on the InVitria catalog with direct checkout. It contains 980 mL of base medium and a 20 mL 50x frozen protein supplement.
Purchase Order
Contact info@invitria.com or a Product Applications team member at InVitria to submit a PO directly.
Bulk pricing
Volumes beyond the 1 L kit are quoted. The bulk pricing request form routes to InVitria with the OptiVERO product name and number attached. The right path for commercial-scale vaccine and viral vector manufacturing supply.
Regional distribution
Outside direct ordering, use the Find a Distributor form for regional supply. All customers receive the same product, Certificate of Analysis, and technical support regardless of channel.

Common questions

Peer-Reviewed Publications

OptiVERO® is built for these applications